Models of Viral Kinetics and Drug Resistance in HIV-1 Infection
- 1 October 1998
- journal article
- review article
- Published by Mary Ann Liebert Inc in AIDS Patient Care and STDs
- Vol. 12 (10) , 769-774
- https://doi.org/10.1089/apc.1998.12.769
Abstract
Mathematical models have become an increasingly valuable tool in HIV research. In particular, the mathematical analysis of drug-induced perturbations of the steady-state viral load in chronically infected patients has led to fundamental new insights into HIV dynamics in vivo and demonstrated that there is highly active viral replication throughout the course of infection. The same models can be used to address issues related to drug resistance and may eventually provide theoretical guidelines for the design of efficient treatment strategies. The goal of this article is to illustrate to a readership with nonmathematical background how these models work, what key assumptions they make, and which questions they may help to answer.Keywords
This publication has 28 references indexed in Scilit:
- Pre–existence and emergence of drug resistance in HIV–1 infectionProceedings Of The Royal Society B-Biological Sciences, 1997
- Anti-viral Drug Treatment: Dynamics of Resistance in Free Virus and Infected Cell PopulationsJournal of Theoretical Biology, 1997
- Population Dynamics of Immune Responses to Persistent VirusesScience, 1996
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)The Journal of Infectious Diseases, 1995
- HIV results in the frameNature, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Competition between zidovudine-sensitive and zidovudine-resistant strains of HIVAIDS, 1992
- Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapyThe Lancet, 1990